Atomoxetine Hydrochloride-Associated Transient Psychosis in an Adolescent with Attention-Deficit/Hyperactivity Disorder and Mild Mental Retardation

This concise volume contains a wealth of information on scoring and interpreting the WISC–III. There are chapters on gifted children, mental retardation, attention deficit hyperactivity disorder, language impairment, hearing impairment, minority and culturally diverse children, and also emotionally disturbed children. The text also addresses the use of the WISC–III with achievement tests, accurately recording and interpreting behavioral observations over the course of administering a WISC–III, and also the neuropsychological basis of intelligence and the WISC–III.

Download Full-text

Co-morbidity and treatment of attention deficit hyperactivity disorder in Saudi Arabia

Eastern Mediterranean Health Journal ◽

10.26719/2003.9.5-6.988 ◽

2003 ◽

Vol 9 (5-6) ◽

pp. 988-995

Author(s):

F. A. Al Haidar

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Language Disorder ◽

Behavioural Therapy ◽

Psychiatric Clinic ◽

Mild Mental Retardation ◽

Hyperactivity Disorder ◽

Treatment Characteristics ◽

Co Morbidity ◽

Child Psychiatric

To review the experience of a child psychiatric clinic regarding co-morbidity and treatment characteristics of children with attention deficit hyperactivity disorder [ADHD], a retrospective study was done on patients under 19 years who were attending the clinic and were diagnosed with ADHD. Co-morbidity and treatment characteristics were also studied. ADHD was diagnosed in 25.5% of the patients. Of these, 28.3% had coexistent expressive language disorder and 38.7% coexistent mild mental retardation. A psychostimulant [methylphenidate] was prescribed to 23.6% while antidepressants [primarily imipramine] were prescribed to 35.9%. Behavioural therapy was the most commonly offered psychotherapy. Antidepressants were used more than psychostimulants. Psychotropics had a more beneficial effect than psychotherapy

Download Full-text

Mental Retardation and ADHD!

PEDIATRICS ◽

10.1542/peds.89.2.351 ◽

1992 ◽

Vol 89 (2) ◽

pp. 351-351

Author(s):

ROBERT G. VOIGT ◽

GRAEME H. JOHNSON ◽

FRANK R. BROWN

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Mental Retardation ◽

General Practitioner ◽

Cognitive Function ◽

Motor Activity ◽

Attention Deficit ◽

Impulse Control ◽

Activity Levels ◽

Hyperactivity Disorder ◽

Effective Medication

To the Editor.— This letter cautions the general practitioner about prescribing methylphenidate to children with mental retardation, despite the reported utility in nine patients.1 Methylphenidate is understood to be an effective medication for treatment of children who have attention-deficit hyperactivity disorder (ADHD), characterized by a developmentally inappropriate attention span, level of impulsiveness, and motor activity. For the general practitioner, ADHD typically is identified in children with normal neurodevelopment. Because children with mental retardation may have attention spans, impulse control, and activity levels inappropriate for their chronologic age, albeit appropriate for their underlying level of cognitive function, we are concerned about the general practitioner's ability to identify ADHD in children with mental retardation.

Download Full-text